The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFIRI-ramucirumab (FOLFIRI-Ram) versus ramucirumab-paclitaxel (Ram-Pac) in the second line (2L) for patients with advanced upper gastrointestinal (UGI) cancer: A real-world propensity-score matched analysis of survival.
 
Timothy Brown
Research Funding - Flatiron Health (Inst)
 
Peifeng Ruan
Research Funding - Flatiron Health (Inst)
 
Amy Jones
No Relationships to Disclose
 
Nilesh Verma
Consulting or Advisory Role - Guardant Health
Speakers' Bureau - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Matthew Porembka
No Relationships to Disclose
 
Shahed Badiyan
No Relationships to Disclose
 
Sam Wang
No Relationships to Disclose
 
Nina Sanford
Honoraria - AstraZeneca; Signatera; Total Health Conferencing
 
Syed Kazmi
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Consulting or Advisory Role - Taiho Oncology